Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Foreign Corrupt Practices Act Deferred Prosecution Agreement

To resolve a Foreign Corrupt Practices Act (FCPA) investigation, Pfizer subsidiary Pfizer H.C.P. Corporation agreed to pay a $15 million penalty and enter into a deferred prosecution agreement with the Department of Justice (DOJ). The DOJ filed a two-count criminal information charging Pfizer H.C.P. with conspiracy and violations of the FCPA in connection with improper payments made to government officials in Bulgaria, Croatia, Kazakhstan, and Russia. According to the DOJ, between 1997 and 2006, Pfizer H.C.P. made more than $2 million in improper payments to hospital administrators, members of regulatory and purchasing committees, and other health care professionals in these countries in order to influence decisions regarding the approval and registration of Pfizer products, the award of pharmaceutical tenders, and the level of sales of Pfizer products. Pfizer and Wyeth LLC (acquired by Pfizer in 2009) also reached settlements in the matter with the Securities and Exchange Commission (SEC) (see Pfizer instance, “Foreign Corrupt Practices Act Violations – SEC Settlement”).

Misconduct Type
Ethics
Enforcement Agency
Justice
Contracting Party
None
Court Type
Criminal
Disposition
Deferred Prosecution Agreement
Date of DPA Announcement
8/7/2012
Contractors Involved Penalty
Total
Pfizer, Inc. $15,000,000
Further Information Released
Deferred Prosecution Agreement 8/7/2012
DOJ Press Release 8/7/2012

See also:

Federal Contractor Misconduct Database